124 related articles for article (PubMed ID: 1944328)
1. Bulky adducts detected by 32P-postlabeling in DNA modified by oxidative damage in vitro. Comparison with rat lung I-compounds.
Randerath K; Yang PF; Danna TF; Reddy R; Watson WP; Randerath E
Mutat Res; 1991; 250(1-2):135-44. PubMed ID: 1944328
[TBL] [Abstract][Full Text] [Related]
2. Formation of ribonucleotides in DNA modified by oxidative damage in vitro and in vivo. Characterization by 32P-postlabeling.
Randerath K; Reddy R; Danna TF; Watson WP; Crane AE; Randerath E
Mutat Res; 1992 Sep; 275(3-6):355-66. PubMed ID: 1383776
[TBL] [Abstract][Full Text] [Related]
3. DNA damage induced by cigarette smoke condensate in vitro as assayed by 32P-postlabeling. Comparison with cigarette smoke-associated DNA adduct profiles in vivo.
Randerath E; Danna TF; Randerath K
Mutat Res; 1992 Jul; 268(1):139-53. PubMed ID: 1378180
[TBL] [Abstract][Full Text] [Related]
4. In vitro inhibition by N-acetylcysteine of oxidative DNA modifications detected by 32P postlabeling.
Izzotti A; Orlando M; Gasparini L; Scatolini L; Cartiglia C; Tulimiero L; De Flora S
Free Radic Res; 1998 Feb; 28(2):165-78. PubMed ID: 9645393
[TBL] [Abstract][Full Text] [Related]
5. DNA adduction by phenol, hydroquinone, or benzoquinone in vitro but not in vivo: nuclease P1-enhanced 32P-postlabeling of adducts as labeled nucleoside bisphosphates, dinucleotides and nucleoside monophosphates.
Reddy MV; Bleicher WT; Blackburn GR; Mackerer CR
Carcinogenesis; 1990 Aug; 11(8):1349-57. PubMed ID: 2387021
[TBL] [Abstract][Full Text] [Related]
6. Bulky DNA-adduct formation induced by Ni(II) in vitro and in vivo as assayed by 32P-postlabeling.
Chang J; Watson WP; Randerath E; Randerath K
Mutat Res; 1993 Apr; 291(2):147-59. PubMed ID: 7680419
[TBL] [Abstract][Full Text] [Related]
7. Structural origins of bulky oxidative DNA adducts (type II I-compounds) as deduced by oxidation of oligonucleotides of known sequence.
Randerath K; Randerath E; Smith CV; Chang J
Chem Res Toxicol; 1996; 9(1):247-54. PubMed ID: 8924599
[TBL] [Abstract][Full Text] [Related]
8. 32P-postlabeling detection of thymine glycols: evaluation of adduct recoveries after enhancement with affinity chromatography, nuclease P1, nuclease S1, and polynucleotide kinase.
Reddy MV; Bleicher WT; Blackburn GR
Cancer Commun; 1991 Apr; 3(4):109-17. PubMed ID: 2025496
[TBL] [Abstract][Full Text] [Related]
9. Detection and characterization by 32P-postlabelling of DNA adducts induced by a Fenton-type oxygen radical-generating system.
Carmichael PL; Shé MN; Phillips DH
Carcinogenesis; 1992 Jul; 13(7):1127-35. PubMed ID: 1638678
[TBL] [Abstract][Full Text] [Related]
10. Monophosphate 32P-postlabeling assay of DNA adducts from 1,2:3,4-diepoxybutane, the most genotoxic metabolite of 1,3-butadiene: in vitro methodological studies and in vivo dosimetry.
Mabon N; Moorthy B; Randerath E; Randerath K
Mutat Res; 1996 Nov; 371(1-2):87-104. PubMed ID: 8950354
[TBL] [Abstract][Full Text] [Related]
11. A new sensitive 32P-postlabeling assay based on the specific enzymatic conversion of bulky DNA lesions to radiolabeled dinucleotides and nucleoside 5'-monophosphates.
Randerath K; Randerath E; Danna TF; van Golen L; Putman KL
Carcinogenesis; 1989 Jul; 10(7):1231-9. PubMed ID: 2544310
[TBL] [Abstract][Full Text] [Related]
12. Examination of microsomal cytochrome P450-catalyzed in vitro activation of o-phenylphenol to DNA binding metabolite(s) by 32P-postlabeling technique.
Pathak DN; Roy D
Carcinogenesis; 1992 Sep; 13(9):1593-7. PubMed ID: 1394845
[TBL] [Abstract][Full Text] [Related]
13. Improvement in the diagnostic potential of 32P-postlabeling analysis demonstrated by the selective formation and comparative analysis of nitrated-PAH-derived adducts arising from diesel particle extracts.
Gallagher JE; Kohan MJ; George MH; Lewtas J
Carcinogenesis; 1991 Sep; 12(9):1685-91. PubMed ID: 1893529
[TBL] [Abstract][Full Text] [Related]
14. 32P-postlabeling of bile components: bulky adduct-like behavior in polyethyleneimine-cellulose thin layer chromatography.
Vulimiri SV; Smith CV; Randerath E; Randerath K
Carcinogenesis; 1994 Sep; 15(9):2061-4. PubMed ID: 7923604
[TBL] [Abstract][Full Text] [Related]
15. Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation.
Culp SJ; Roberts DW; Talaska G; Lang NP; Fu PP; Lay JO; Teitel CH; Snawder JE; Von Tungeln LS; Kadlubar FF
Mutat Res; 1997 Aug; 378(1-2):97-112. PubMed ID: 9288889
[TBL] [Abstract][Full Text] [Related]
16. Formation and persistence of sterigmatocystin--DNA adducts in rat liver determined via 32P-postlabeling analysis.
Reddy MV; Irvin TR; Randerath K
Mutat Res; 1985 Oct; 152(1):85-96. PubMed ID: 4047087
[TBL] [Abstract][Full Text] [Related]
17. 32P-postlabeling DNA damage assays: PAGE, TLC, and HPLC.
Shibutani S; Kim SY; Suzuki N
Methods Mol Biol; 2006; 314():307-21. PubMed ID: 16673890
[TBL] [Abstract][Full Text] [Related]
18. High-resolution TLC mapping and characterization of 32P-postlabeled monophosphate 7,12-dimethylbenz[a]anthracene-DNA adducts.
Yang PF; Randerath K
Carcinogenesis; 1990 Jan; 11(1):159-64. PubMed ID: 2104782
[TBL] [Abstract][Full Text] [Related]
19. 32P-postlabeling assay for carcinogen-DNA adducts: nuclease P1-mediated enhancement of its sensitivity and applications.
Reddy MV; Randerath K
Environ Health Perspect; 1987 Dec; 76():41-7. PubMed ID: 2834194
[TBL] [Abstract][Full Text] [Related]
20. Intensification and depletion of specific bulky renal DNA adducts (I-compounds) following exposure of male F344 rats to the renal carcinogen ferric nitrilotriacetate (Fe-NTA).
Randerath E; Watson WP; Zhou GD; Chang J; Randerath K
Mutat Res; 1995 Feb; 341(4):265-79. PubMed ID: 7531286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
